Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Candice W. Bolan

Matched on ORCID iD 0000-0002-9847-3599; OpenAlex author ID A5055352623. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
58
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 3 papers · 2024: 1 paper · 2025: 2 papers

Papers 11

  1. Cyst-X: AI-Powered Pancreatic Cancer Risk Prediction from Multicenter MRI in Centralized and Federated Learning Co-author DOI 10.21203/rs.3.rs-7236860/v1↗
  2. Factors Associated With Aborted Whipple Procedures for Periampullary Carcinoma: A Multicenter Case-Control Study by the SAR Pancreatic Ductal Adenocarcinoma Di… Co-author DOI 10.2214/ajr.24.32160↗
  3. Temporal Trends in Body Composition and Metabolic Markers Prior to Diagnosis of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.cgh.2024.03.038↗
  4. Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of ab… Co-author DOI 10.1007/s00261-022-03693-0↗
  5. Determination of "borderline resectable" pancreatic cancer - A global assessment of 30 shades of grey. Co-author DOI 10.1016/j.hpb.2023.07.883↗
  6. Bounding box-based 3D AI model for user-guided volumetric segmentation of pancreatic ductal adenocarcinoma on standard-of-care CTs. Co-author DOI 10.1016/j.pan.2023.05.008↗
  7. Prevalence, features, and explanations of missed and misinterpreted pancreatic cancer on imaging: a matched case-control study. Last author DOI 10.1007/s00261-022-03671-6↗
  8. Editorial Comment: MRI Is Strengthening the Practice for Pancreatic Cancer Imaging. Co-author DOI 10.2214/ajr.22.28093↗
  9. Pancreatic steatosis on computed tomography is an early imaging feature of pre-diagnostic pancreatic cancer: A preliminary study in overweight patients. First author DOI 10.1016/j.pan.2021.01.003↗
  10. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging. First author DOI 10.1007/s00261-018-1686-x↗
  11. Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study. Co-author DOI 10.1089/pancan.2018.0011↗

Closest collaborators

The 25 strongest of 58 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael B. Wallace · 5 shared papers, 2018–2025 · strength 0.77
  2. Jeanin Elise van Hooft · 3 shared papers, 2021–2024 · strength 0.52
  3. Megan M.L. Engels · 2 shared papers, 2022–2024 · strength 0.37
  4. Sanne A.M. Hoogenboom · 2 shared papers, 2021–2022 · strength 0.32
  5. Zhen J. Wang · 2 shared papers, 2023–2025 · strength 0.29
  6. Marc Zins · 2 shared papers, 2023–2025 · strength 0.29
  7. Jin Peng He · 2 shared papers, 2023–2025 · strength 0.29
  8. Samuel Joseph Galgano · 2 shared papers, 2023–2025 · strength 0.29
  9. Lyndon Luk · 2 shared papers, 2023–2025 · strength 0.29
  10. Erik V. Soloff · 2 shared papers, 2023–2025 · strength 0.29
  11. Atif Zaheer · 2 shared papers, 2023–2025 · strength 0.29
  12. Elizabeth M. Hecht · 2 shared papers, 2023–2025 · strength 0.29
  13. Avinash R. Kambadakone · 2 shared papers, 2023–2025 · strength 0.29
  14. Richard Kinh Gian Do · 2 shared papers, 2023–2025 · strength 0.29
  15. Linda Chi Hang Chu · 2 shared papers, 2023–2025 · strength 0.29
  16. Ajit Harishkumar Goenka · 2 shared papers, 2023 · strength 0.27
  17. Massimo Raimondo · 2 shared papers, 2018–2021 · strength 0.23
  18. Andrew W. Bowman · 1 shared paper, 2019 · strength 0.20
  19. Yan Bi · 1 shared paper, 2024 · strength 0.20
  20. Monique Esther van Leerdam · 1 shared paper, 2024 · strength 0.20
  21. Derk C.F. Klatte · 1 shared paper, 2024 · strength 0.20
  22. Ulaş Bağcı · 1 shared paper, 2025 · strength 0.17
  23. Rajesh N. Keswani · 1 shared paper, 2025 · strength 0.17
  24. Marco J. Bruno · 1 shared paper, 2025 · strength 0.17
  25. Tamas A. Gonda · 1 shared paper, 2025 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.